SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-279891
Filing Date
2020-10-28
Accepted
2020-10-28 16:35:57
Documents
14
Period of Report
2020-10-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d91080d8k.htm   iXBRL 8-K 25994
2 EX-99.1 d91080dex991.htm EX-99.1 9849
6 GRAPHIC g91080g1028074415837.jpg GRAPHIC 4784
  Complete submission text file 0001193125-20-279891.txt   169299

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20201028.xsd EX-101.SCH 3059
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20201028_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20201028_pre.xml EX-101.PRE 11401
7 EXTRACTED XBRL INSTANCE DOCUMENT d91080d8k_htm.xml XML 3385
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14710 | Film No.: 201269145
SIC: 2834 Pharmaceutical Preparations